Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 29, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Li Watsek Reiterated (ALXO) at Buy on, May 29th, 2024
Li Watsek of Cantor Fitzgerald, Reiterated "ALX Oncology Holdings Inc." (ALXO) at Buy on, May 29th, 2024.
Li has made no other calls on ALXO in the last 4 months.
There are 3 other peers that have a rating on ALXO. Out of the 3 peers that are also analyzing ALXO, 1 agrees with Li's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Bradley Canino of "Stifel" Downgraded from Strong Buy to Hold and Increased Target to $14 on, Friday, March 8th, 2024
These are the ratings of the 2 analyists that currently disagree with Li
- Swayampakula Ramakanth of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $20 on, Wednesday, April 10th, 2024
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $21 on, Friday, March 8th, 2024
